使用Biograph Vision PET/CT优化肿瘤89Zr免疫PET成像的扫描时长与图像质量
本研究比较了基于光电倍增管的Biograph mCT与基于硅光电倍增管的Biograph Vision PET/CT在89Zr免疫PET成像中的半定量性能,并评估Vision缩短扫描时长对半定量参数和图像质量的影响。结果显示,在EARL标准1兼容重建协议下,两系统100%采集时间的半定量结果相当;Vision数据在缩短至75%和50%采集时间时半定量结果仍与100%采集时间相当。结论认为,使用Vision可将89Zr免疫PET扫描时长较mCT缩短最多50%,同时采用EARL1兼容重建协议可保持图像质量。
要点
- 在EARL标准1兼容重建下,Vision与mCT的89Zr免疫PET半定量结果相当。
- Vision数据在75%和50%采集时间下,半定量结果与100%采集时间相当。
- 使用Vision可将89Zr免疫PET扫描时长较mCT缩短最多50%,并保持图像质量。
核心结论
- 使用Vision进行89Zr免疫PET成像时,采用EARL1兼容重建协议,扫描时长可较使用mCT缩短最多50%,同时保持图像质量。
研究设计与样本
- 数据于注射37 MBq 89Zr标记单克隆抗体后第4天采集,5例患者在两台系统上接受双扫描协议,10例患者仅在Vision上扫描。
- PET图像重建使用三种协议:一种相机依赖协议,以及符合欧洲核医学研究有限公司(EARL)标准1和标准2的协议。
- Vision数据以列表模式采集,并重处理以获得更短扫描时长的图像;从肿瘤病灶和健康组织导出半定量PET图像参数,以评估系统间和扫描时长间的差异。
- 由两名核医学医师对Vision不同重建图像进行图像质量视觉评分。
主要发现
- 当两系统图像均使用100%采集时间并遵循EARL标准1兼容重建协议重建时,半定量结果相当。
- 对于Vision数据,符合EARL1标准的重建图像在较短扫描时长(75%和50%)下,半定量结果仍与100%采集时间相当。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Monoclonal antibody (mAb)-based PET (immunoPET) imaging can characterise tumour lesions non-invasively. It may be a valuable tool to determine which patients may benefit from treatment with a specific monoclonal antibody (mAb) and evaluate treatment response. For 89Zr immunoPET imaging, higher sensitivity of state-of-the art PET/CT systems equipped with silicon photomultiplier (SiPM)-based detector elements may be beneficial as the low positron abundance of 89Zr causes a low signal-to-noise level. Moreover, the long physical half-life limits the amount of activity that can be administered to the patients leading to poor image quality even when using long scan durations. Here, we investigated the difference in semiquantitative performance between the PMT-based Biograph mCT, our clinical reference system, and the SiPM-based Biograph Vision PET/CT in 89Zr immunoPET imaging. Furthermore, the effects of scan duration reduction using the Vision on semiquantitative imaging parameters and its influence on image quality assessment were evaluated. METHODS: Data were acquired on day 4 post 37 MBq 89Zr-labelled mAb injection. Five patients underwent a double scan protocol on both systems. Ten patients were scanned only on the Vision. For PET image reconstruction, three protocols were used, i.e. one camera-dependent protocol and European Association of Nuclear Medicine Research Limited (EARL) standards 1 and 2 compliant protocols. Vision data were acquired in listmode and were reprocessed to obtain images at shorter scan durations. Semiquantitative PET image parameters were derived from tumour lesions and healthy tissues to assess differences between systems and scan durations. Differently reconstructed images obtained using the Vision were visually scored regarding image quality by two nuclear medicine physicians. RESULTS: When images were reconstructed using 100% acquisition time on both systems following EARL standard 1 compliant reconstruction protocols, results regarding semiquantification were comparable. For Vision data, reconstructed images that conform to EARL1 standards still resulted in comparable semiquantification at shorter scan durations (75% and 50%) regarding 100% acquisition time. CONCLUSION: Scan duration of 89Zr immunoPET imaging using the Vision can be decreased up to 50% compared with using the mCT while maintaining image quality using the EARL1 compliant reconstruction protocol.
引用
- van Sluis J, Boellaard R, Dierckx RAJO, et al. Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET/CT. Eur J Nucl Med Mol Imaging. 2023. PMID: 36947185. doi:10.1007/s00259-023-06194-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。